scispace - formally typeset
J

John Repass

Researcher at University of Texas MD Anderson Cancer Center

Publications -  5
Citations -  537

John Repass is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Transgene. The author has an hindex of 4, co-authored 5 publications receiving 495 citations.

Papers
More filters
Journal ArticleDOI

NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation

TL;DR: Gain-of-function studies establish the integral role for NANOG in neoplastic processes and shed light on its mechanisms of action in tumorigenesis, as well as establishing the importance of CXCR4, IGFBP5, CD133 and ALDH1 in this work.
Journal ArticleDOI

IL7-hCD25 and IL7-Cre BAC transgenic mouse lines: new tools for analysis of IL-7 expressing cells.

TL;DR: Two bacterial artificial chromosome transgenic mouse lines are generated in which IL‐7 regulatory elements drive expression of either Cre recombinase or a human CD25 (hCD25) cell surface reporter molecule and these transgenic lines provide novel genetic tools to identifyIL‐7 producing cells in various tissues and to manipulate gene expression selectively in IL‐ 7 expressing cells.
Journal ArticleDOI

Dietary energy balance modulates prostate cancer progression in Hi-Myc mice.

TL;DR: Findings suggest that enhanced growth factor (Akt/mTORC1 and STAT3) and inflammatory (NFκB and cytokines) signaling may play a role in dietary energy balance effects on prostate cancer progression in Hi-Myc mice.